Skip to content

EBITDA at other companies

IAR
Integra LifeSciencesIART
$53.68M+111%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$14.44M+0.2%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.39M-38.5%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Stryker logo
StrykerSYK
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Calculated from Sanara MedTech Inc.’s reported figures.

$2.6Mebit+
$587.3KDepreciation Depletion & Amortization
=$3.23M

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s EBITDA?
Sanara MedTech Inc. (SMTI) reported EBITDA of $3.23M in Q1 2026.
How has Sanara MedTech Inc.'s EBITDA changed year-over-year?
Sanara MedTech Inc.'s EBITDA increased by 65.8% year-over-year, from $1.95M to $3.23M.
What is the long-term trend for Sanara MedTech Inc.'s EBITDA?
Over 4 years (2021 to 2025), Sanara MedTech Inc.'s EBITDA has grown at a 6.5% compound annual growth rate (CAGR), from -$6.78M to $8.73M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.